Evaluasi Penggunaan Aspirin Jangka Panjang terhadap Fungsi Ginjal Pasien Penyakit Jantung Koroner

https://doi.org/10.22146/jmpf.53312

Ema Pristi Yunita(1*), Puji Astuti Nur Hidayanti(2), Cholid Tri Tjahjono(3)

(1) Jurusan Farmasi, Fakultas Kedokteran, Universitas Brawijaya, Malang Pusat Studi Molekul Cerdas Berbasis Sumber Genetik Alami (SMONAGENES), Universitas Brawijaya, Malang, Indonesia
(2) Program Studi Sarjana Farmasi, Fakultas Kedokteran, Universitas Brawijaya, Malang
(3) Departemen Kardiologi, Fakultas Kedokteran, Universitas Brawijaya, RSUD Dr Saiful Anwar, Malang
(*) Corresponding Author

Abstract


Low-dose aspirin (75-100 mg/day) is a long-term platelet antiaggregation therapy for certain coronary heart disease (CHD) patients. This study aims to evaluate the long-term use of aspirin on kidney function by examining the changes in the levels of serum creatinine, blood urea nitrogen (BUN), and creatinine clearance of CHD patients. The research method used was a prospective observational cohort analysis. The number of study subjects was 37 CHD patients who took 80 mg/day of aspirin and never experienced kidney disease. Serum creatinine and BUN levels were examined in the 1st and 3rd month of the study. Patient creatinine clearance values were calculated using the Cockcroft-Gault equation. The results of the study showed that the mean levels of serum creatinine, BUN, and creatinine clearance on the 1st and 3rd month were 1.03 ± 0.27 mg/dL and 1.03 ± 0.29 mg/dL; 13.05 ± 4.10 mg/dL and 14.65 ± 4.44 mg/dL; 73.16 ± 18.14 mL/min and 72.92 ± 19.76 mL/min, respectively. The paired t-test results showed that the differences in the mean of creatinine serum, BUN, and creatinine clearance on the 1st and 3rd month were not statistically significant (p > 0.05). The One Way ANOVA test results on the effect of the duration of aspirin use on kidney function were also not statistically significant (p > 0.05) however there is a tendency to decrease creatinine clearance and increase in serum creatinine and BUN. Long-term use of low-dose aspirin has the potential to cause a decrease in kidney function that is seen from a decrease in creatinine clearance as well as an increase in serum creatinine and BUN.


Keywords


Aspirin dosis-rendah; BUN; kreatinin serum; penyakit jantung koroner

Full Text:

PDF


References

  1. Kemenkes. Penyajian Pokok-Pokok Hasil Riset Kesehatan Dasar 2013 (Riskesdas 2013). Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. http://kesga.kemkes.go.id/images/pedoman/Data Riskesdas 2013.pdf. Published 2013. Accessed April 25, 2020.
  2. Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Hear J Acute Cardiovasc Care. 2012;1(1):60-74. doi:10.1177/2048872612441582.
  3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315-2381. doi:10.1093/eurheartj/ehw106.
  4. Yunita EP, Zulkarnain BS, Aminuddin M. Aspirin resistance in coronary artery disease with hypertensive patients. Indones J Clin Pharm. 2015;4(1):28-38. doi:10.15416/ijcp.2015.4.1.28.
  5. Mekaj YH, Daci FT, Mekaj AY. New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag. 2015;11:1449-1456. doi:10.2147/TCRM.S92222.
  6. Li Y, Xia W, Zhao F, Wen Z, Zhang A, Huang S, et al. Prostaglandins in the pathogenesis of kidney diseases. Oncotarget. 2018;9(41):26586-26602. doi:10.18632/oncotarget.25005.
  7. Sarsam J, Adeep Y. Assessing the effects of low dose aspirin on uricacid and renal function in healthy adults. Ann Coll Med. 2009;35(2):154-159. doi:10.33899/mmed.2009.8848.
  8. Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D. Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J. 2006;8:679-682.
  9. Yunita EP, Rochmawati PE. NSAID effects for kidney function in osteoarthritis patient. In: Nugraha AS, Dewi IP, Pratama ANW, et al., eds. 1st International Conference on Medicine and Health Sciences. Jember: Faculty of Pharmacy, Faculty of Dentristy, Faculty of Medicine, Faculty of Public Health, School of Nursing, University of Jember; 2016:38.
  10. Dahlan MS. Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. 3rd Ed. Jakarta: Salemba Medika; 2009.
  11. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000;43(1):103-108.
  12. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458-2473. doi:10.1161/CIR.0b013e318235eb4d.
  13. Kumar P. Coronary Artery Disease Clinical Medicine. 8th Ed. Spain: International Edition; 2012.
  14. Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. J Am Coll Cardiovasc Imaging. 2012;5(3):S62-S72. doi:10.1016/j.jcmg.2012.02.003.
  15. Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: A global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Heal. 2017;2:1-8. doi:10.1136/bmjgh-2017-000298.
  16. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Himmelfarb CD, Goldberger ZD, et al. 2019 Guideline on the primary prevention of cardiovascular disease. Am Coll Cardiol. 2019:1-7. doi:10.1002/clc.23218.
  17. Kim SE, Kim N, Lee JY, Park KS, Shin JE, Nam K, et al. Prevalence and risk factors of functional dyspepsia in health check-up population: a nationwide multicenter prospective study. J Neurogastroenterol Motil. 2018;24(4):603-613. doi:10.5056/jnm18068.
  18. Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN. Markers of renal function tests. N Am J Med Sci. 2010;2(4):170-173.
  19. Gounden V, Jialal I. Renal Function Tests. StatPearls Publishing LLC. https://www.ncbi.nlm.nih.gov/books/NBK507821/. Published 2020. Accessed April 25, 2020.
  20. Salgado JV, Neves FA, Bastos MG, França AK, Brito DJ, Santos EM, et al. Monitoring renal function: measured and estimated glomerular filtration rates-a review. Brazilian J Med Biol Res. 2010;43(6):528-536. doi:10.1590/S0100-879X2010007500040.
  21. Hajivandi A, Amiri M. World kidney day 2014: Kidney disease and elderly. J Parathyr Dis. 2014;2(1):3-4. doi:10.12884/jpd.2014.02.
  22. Lamb EJ. Kidney Fun In Clinical Chemistry and Molecular Diagnosis. 4th Ed. America: Elsevier; 2010:797-831.
  23. Mahto AK. Comparison of different doses of aspirin on renal function in elderly patients. Int J Med Heal Res. 2017;3(11):146-148.



DOI: https://doi.org/10.22146/jmpf.53312

Article Metrics

Abstract views : 4488 | views : 16767

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats